Morphine Completed Phase 4 Trials for Pain NOS / Sickle Cell Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03682211Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children
NCT02673372Geriatric Ketamine for Pain Management Study
NCT01951963Sub-dissociative Ketamine for the Management of Acute Pediatric Pain
NCT01322360Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects
NCT01830296Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain
NCT01835262Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department
NCT01918917Adding Intra-articular Dexmedetomidine to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery
NCT01953978The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery
NCT02223533Multimodal Analgesia With Interfascial Continuous Wound Infiltration: A Randomized Clinical Trial
NCT02790099Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine
NCT02848729A Study to Evaluate the Drug-Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen
NCT02912195Intravenous Lidocaine Versus Morphine for Severe Pain in the ED
NCT00640042Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza